Patents by Inventor Amanda RICKARD

Amanda RICKARD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of DUX4 induction for regulation of muscle function
    Patent number: 11806343
    Abstract: Disclosed are methods and compositions for the treatment of facioscapulohumeral muscular dystrophy. In some cases, the methods and compositions involve the use of kinase inhibitors include Src, Syk, Abl, Tie, Flt, ErbB, Trk, PRKDC, and Yes families to repress DUX4 expression in muscle cells. Further disclosed are methods and cell based assays for screening compounds for the treatment of facioscapulohumeral muscular dystrophy.
    Type: Grant
    Filed: July 14, 2021
    Date of Patent: November 7, 2023
    Assignee: Sonic Master Limited
    Inventors: Amanda Rickard, Uli Schmidt, Alexander Kiselyov
  • Inhibitors of DUX4 Induction for Regulation of Muscle Function
    Publication number: 20210361641
    Abstract: Disclosed are methods and compositions for the treatment of facioscapulohumeral muscular dystrophy. In some cases, the methods and compositions involve the use of kinase inhibitors include Src, Syk, Abl, Tie, Flt, ErbB, Trk, PRKDC, and Yes families to repress DUX4 expression in muscle cells. Further disclosed are methods and cell based assays for screening compounds for the treatment of facioscapulohumeral muscular dystrophy.
    Type: Application
    Filed: July 14, 2021
    Publication date: November 25, 2021
    Inventors: Amanda Rickard, Uli Schmidt, Alexander Kiselyov
  • Inhibitors of DUX4 induction for regulation of muscle function
    Patent number: 11065243
    Abstract: Disclosed are methods and compositions for the treatment of facioscapulohumeral muscular dystrophy. In some cases, the methods and compositions involve the use of kinase inhibitors include Src, Syk, Abl, Tie, Flt, ErbB, Trk, PRKDC, and Yes families to repress DUX4 expression in muscle cells. Further disclosed are methods and cell based assays for screening compounds for the treatment of facioscapulohumeral muscular dystrophy.
    Type: Grant
    Filed: October 26, 2018
    Date of Patent: July 20, 2021
    Assignee: Sonic Master Limited
    Inventors: Amanda Rickard, Uli Schmidt, Alexander Kiselyov
  • Modulators of DUX4 for Regulation of Muscle Function
    Publication number: 20210196723
    Abstract: Disclosed herein are methods and compositions for the treatment of facioscapulohumeral muscular dystrophy and other muscle diseases or disorders. In some cases, the methods and compositions involve the use of methyltransferase inhibitors to inhibit or repress DUX4 expression in muscle cells. Further disclosed herein are methods and cell-based assays for screening compounds for the treatment of facioscapulohumeral muscular dystrophy and other muscle diseases.
    Type: Application
    Filed: January 11, 2021
    Publication date: July 1, 2021
    Inventors: Amanda Rickard, Anabel De La Garza, Uli Schmidt, Alexander Kiselyov
  • Modulators of DUX4 for regulation of muscle function
    Patent number: 10933068
    Abstract: Disclosed herein are methods and compositions for the treatment of facioscapulohumeral muscular dystrophy and other muscle diseases or disorders. In some cases, the methods and compositions involve the use of methyltransferase inhibitors to inhibit or repress DUX4 expression in muscle cells. Further disclosed herein are methods and cell based assays for screening compounds for the treatment of facioscapulohumeral muscular dystrophy and other muscle diseases.
    Type: Grant
    Filed: May 26, 2017
    Date of Patent: March 2, 2021
    Assignee: Sonic Master Limited
    Inventors: Amanda Rickard, Anabel De La Garza, Uli Schmidt, Alexander Kiselyov
  • Inhibitors of Dux4 Induction for Regulation of Muscle Function
    Publication number: 20200330452
    Abstract: Disclosed are methods and compositions for the treatment of facioscapulohumeral muscular dystrophy. In some cases, the methods and compositions involve the use of kinase inhibitors include Src, Syk, Abl, Tie, Flt, ErbB, Trk, PRKDC, and Yes families to repress DUX4 expression in muscle cells. Further disclosed are methods and cell based assays for screening compounds for the treatment of facioscapulohumeral muscular dystrophy.
    Type: Application
    Filed: October 26, 2018
    Publication date: October 22, 2020
    Inventors: Amanda Rickard, Uli Schmidt, Alexander Kiselyov
  • MODULATORS OF DUX4 FOR REGULATION OF MUSCLE FUNCTION
    Publication number: 20190298727
    Abstract: Disclosed herein are methods and compositions for the treatment of facioscapulohumeral muscular dystrophy and other muscle diseases or disorders. In some cases, the methods and compositions involve the use of methyltransferase inhibitors to inhibit or repress DUX4 expression in muscle cells. Further disclosed herein are methods and cell based assays for screening compounds for the treatment of facioscapulohumeral muscular dystrophy and other muscle diseases.
    Type: Application
    Filed: May 26, 2017
    Publication date: October 3, 2019
    Inventors: Amanda RICKARD, Anabel DE LA GARZA, Uli SCHMIDT, Alexander KISELYOV